Skip to main content

Just in case you didn’t have the chance to read it yet, be sure to check out Part 1 of our series on Low Dose Naltrexone (LDN)!

Low Dose Naltrexone For Fibromyalgia

Picking up right where we left off last time, researchers have discovered that naltrexone, when given in a dose of 4.5 mg each night at bedtime, appears to work via “boosting” or “priming” the immune system. Upon the discovery that immune cells throughout the body have opioid receptors (the receptors that naltrexone bind to), it was theorized that by taking naltrexone each night at bedtime, an interesting thing might occur – it’s believed that certain elements of the immune system will be “boosted”, such as endorphins and enkephalins. These elements are critical in the regulation of pain and immune function, and are believed to be key in how low dose naltrexone may be helpful in certain conditions such as fibromyalgia. One study conducted in normal volunteers, for example, showed a marked increase in beta-endorphin blood levels in the days following taking low dose naltrexone as described above.

Title: Exploring the Potential of Low Dose Naltrexone for Fibromyalgia Relief

Introduction – Low Dose Naltrexone for Fibromyalgia

Fibromyalgia is a complex and often debilitating chronic pain condition that affects millions of people worldwide. While its exact cause remains elusive, researchers and patients alike are constantly seeking innovative approaches to manage its symptoms. One such avenue gaining attention is the use of Low Dose Naltrexone (LDN), a medication originally developed to treat opioid addiction. In this blog post, we’ll delve into the potential benefits of LDN for fibromyalgia and how it could offer a new ray of hope for those seeking relief.

Understanding Fibromyalgia

Fibromyalgia is characterized by widespread musculoskeletal pain, fatigue, sleep disturbances, and tender points across the body. It’s a condition that greatly impacts the quality of life, often leading to reduced physical activity, increased stress, and emotional distress. Traditional treatment options have been limited to pain relievers, antidepressants, and lifestyle changes. However, the search for more effective solutions has led researchers to explore LDN’s potential.

Low Dose Naltrexone Explained

Naltrexone, in higher doses, is used to help individuals overcome opioid addiction by blocking the effects of opioids. However, at lower doses—typically ranging from 1.5 to 4.5 mg—LDN has shown promise in modulating the immune system, reducing inflammation, and influencing endorphin release. This unique mechanism of action has intrigued researchers studying its potential use in various autoimmune and chronic pain conditions, including fibromyalgia.

The Science Behind LDN and Fibromyalgia

Research into the effects of LDN on fibromyalgia is still in its early stages, but the initial findings are promising. LDN’s ability to interact with the body’s opioid receptors may help regulate pain perception and alleviate the hypersensitivity to pain associated with fibromyalgia. Moreover, LDN’s anti-inflammatory properties could address the chronic inflammation often observed in fibromyalgia patients.

Benefits and Considerations

1. Pain Management: One of the most significant potential benefits of LDN for fibromyalgia patients is its impact on pain relief. By targeting the body’s opioid receptors, LDN might help reduce the severity of pain experienced by individuals with fibromyalgia.

2. Improved Sleep: Sleep disturbances are a hallmark of fibromyalgia. LDN’s influence on endorphins and pain perception could lead to improved sleep quality and patterns.

3. Minimal Side Effects: LDN’s lower dosage minimizes the risk of side effects commonly associated with higher doses. However, consulting a medical professional before starting LDN is essential to ensure safety and proper dosing.

Consult Your Healthcare Provider

While the potential benefits of LDN for fibromyalgia are promising, it’s crucial to approach any new treatment option with caution. Consultation with a qualified healthcare provider is essential before considering LDN or making any changes to your treatment plan. They can assess your individual health profile, offer personalized guidance, and monitor your progress.

In Conclusion

Low Dose Naltrexone offers a fresh perspective in the realm of fibromyalgia treatment, holding the potential to alleviate pain, enhance sleep quality, and improve overall well-being. As research continues to uncover the intricacies of LDN’s effects on fibromyalgia, it’s an exciting time for patients and medical professionals alike. If you’re someone seeking alternative approaches to managing fibromyalgia symptoms, LDN could be a topic worth discussing with your healthcare provider.

Low Dose Naltrexone (LDN) holds promise as a potential therapeutic option for managing fibromyalgia symptoms. By modulating the immune system, reducing inflammation, and increasing natural pain-relieving chemicals, LDN addresses multiple aspects of fibromyalgia. However, it’s crucial to remember that LDN should be used under the guidance of a medical professional. If you’re considering LDN as part of your fibromyalgia management plan, consult your healthcare provider to determine if it’s the right choice for you.

Remember, the path to managing fibromyalgia is unique for every individual. Stay informed, stay curious, and always prioritize open communication with your healthcare team to explore the best treatment options for your specific needs.

Given that Low Dose Naltrexone For Fibromyalgia appears to work via altering and enhancing the immune system, it would follow that it may be helpful in conditions where the immune system plays a vital role in that condition. For example, low dose naltrexone appears to help reduce some symptoms of fibromyalgia, as demonstrated in small scale clinical trials. In one trial, for example, 60% of patients reported a reduction in fibromyalgia symptoms. Encouragingly, no serious side effects were reported during the study, although a small number of participants reported vivid dreams.

Another small study in women found that low dose naltrexone improved pain scored by nearly 30%. Participants also reported improved quality of life and also improved mood as well. Participants in this study also didn’t report any serious side effects, which is great news for those that are especially sensitive to side effects of medications.

While these particular studies were small, it does indeed show that there is promise in low dose naltrexone and that it does appear to have a beneficial effect in certain conditions, such as fibromyalgia. Looking at Low Dose Naltrexone For Fibromyalgia shows promise.

Remember to check back soon to find out more about low dose naltrexone (LDN)!


Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels. Abstract available at :

Fibromyalgia Symptoms are reduced by low-dose naltrexone: A pilot study. Abstract available at :

Trinova Health is a licensed pharmacy that only engages in compounding in response to a practitioners prescription. A written prescription from a licensed practitioner is required for compounded medication. The information on the site is general in nature and is only intended for use as an educational tool. You should consult your physician or a Trinova Health pharmacist if you have any specific questions relating to the diagnosis and treatment of any health problems. Information and statements about products and health conditions have not been evaluated by the Food and Drugs Administration (FDA), nor has the FDA approved the products to diagnose, cure or prevent disease.

Dr. Eugene Papantoniou

Dr. Eugene Papantoniou has ten years’ experience as a clinical compounding pharmacist with extensive operational and managerial experience at an independent compounding pharmacy. Dr. Papantoniou assisted the pharmacist-in-charge with maintaining all standard operating procedures especially as it relates to quality control, testing programs, and regulatory reporting. Dr. Papantoniou maintains an active interest in low dose naltrexone (LDN) research, mental health, men’s health and fitness/wellness enhancement.

Leave a Reply

Close Menu

Trinova Health

1209 Tech Blvd.
Suite 102
Tampa, FL 33619

T: 813-551-1165